My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 836

    1.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

    Gould MK, Dembitzer AD, Sanders GD, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):789-99.PMID: 10366368 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism.

    Aujesky D, Smith KJ, Cornuz J, Roberts MS.

    Chest. 2005 Sep;128(3):1601-10.PMID: 16162764 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.

    Gómez-Outes A, Rocha E, Martínez-González J, Kakkar VV.

    Pharmacoeconomics. 2006;24(1):81-92.PMID: 16445305 [PubMed - indexed for MEDLINE]Related articles

    4.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

    Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):800-9.PMID: 10366369 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.

    Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB.

    CMAJ. 1998 Oct 20;159(8):931-8.PMID: 9834718 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

    Quinlan DJ, McQuillan A, Eikelboom JW.

    Ann Intern Med. 2004 Feb 3;140(3):175-83.PMID: 14757615 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

    O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M.

    Arch Intern Med. 1999 Oct 25;159(19):2298-304.PMID: 10547169 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.

    Estrada CA, Mansfield CJ, Heudebert GR.

    J Gen Intern Med. 2000 Feb;15(2):108-15.PMID: 10672114 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism.

    Aujesky D, Smith KJ, Cornuz J, Roberts MS.

    Thromb Haemost. 2005 Mar;93(3):592-9.PMID: 15735815 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis.

    Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS.

    Support Care Cancer. 2004 Jul;12(7):531-6. Epub 2004 Feb 21.PMID: 14986076 [PubMed - indexed for MEDLINE]Related articles

    11.

    A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.

    Lynd LD, Goeree R, Crowther MA, O'Brien BJ.

    Can J Clin Pharmacol. 2007 Summer;14(2):e215-26. Epub 2007 Jun 6.PMID: 17556789 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

    Caro JJ, Getsios D, Caro I, O'Brien JA.

    Pharmacoeconomics. 2002;20(9):593-602.PMID: 12141887 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin.

    Smith BJ, Weekley JS, Pilotto L, Howe T, Beven R.

    Intern Med J. 2002 Jan-Feb;32(1-2):29-34.PMID: 11783670 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

    Haentjens P, De Groote K, Annemans L.

    Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.PMID: 15365714 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

    van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E.

    Cochrane Database Syst Rev. 2000;(2):CD001100. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001100. PMID: 10796593 [PubMed - indexed for MEDLINE]Related articles

    16.

    Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

    Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

    Ann Intern Med. 1993 Dec 1;119(11):1105-12.PMID: 8239230 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.

    Huse DM, Cummins G, Taylor DC, Russell MW.

    Am J Manag Care. 2002 Jan;8(1 Suppl):S10-6.PMID: 11822346 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.

    McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ.

    Am J Manag Care. 2004 Sep;10(9):632-42.PMID: 15515996 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.

    Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB.

    Am J Med. 2003 Sep;115(4):298-308. Review.PMID: 12967695 [PubMed - indexed for MEDLINE]Related articles

    20.

    Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

    Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.

    Arch Intern Med. 1998 Sep 14;158(16):1809-12.PMID: 9738611 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity